Press Releases

Media Inquiries - media@caredxinc.com

Date	Title and Summary	Additional Formats
Toggle Summary Nov 17, 2020	CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,	View HTML
Toggle Summary Nov 10, 2020	CareDx to Participate at Upcoming Conferences SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,	View HTML
Toggle Summary Nov 06, 2020	New Publication Shows CareDx’s AlloSure May Be Effective for Monitoring BK Virus in Transplant Patients Research from Johns Hopkins , U niversity of Maryland, and Cedars Sinai Shows AlloSure May Signal BK Virus Progression in Transplant Patients SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,	View HTML
Toggle Summary Nov 06, 2020	CareDx Joins National Kidney Foundation in Virtual Walk for Kidney Patients CareDx’s Chief Marketing Officer Sasha King is the Chair for the Upcoming Pacific Northwest Virtual Kidney Walk SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and	View HTML
Toggle Summary Oct 29, 2020	Peter Maag Appointed Executive Chairman of the Board of Directors of CareDx; Reginald Seeto Appointed President and CEO SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Oct 29, 2020	CareDx Reports Third Quarter 2020 Results SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Oct 21, 2020	CareDx Showcases Leading Transplant Data at ASN 2020 General nephrologists show a growing interest in AlloSure with 11 abstracts and educational symposiums at the largest nephrology meeting SOUTH SAN FRANCISCO, Calif. , Oct. 21, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,	View HTML
Toggle Summary Oct 19, 2020	Medicare Proposes to Maintain Current Reimbursement Process for AlloMap CMS believes AlloMap reimbursement process is clinically appropriate for heart transplant patients SOUTH SAN FRANCISCO, Calif. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of	View HTML
Toggle Summary Oct 19, 2020	CareDx Leads in Innovation with AlloSeq Portfolio at ASHI 2020 Virtual events to highlight newest innovation and solutions for HLA labs during ASHI conference SOUTH SAN FRANCISCO, Calif. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of	View HTML
Toggle Summary Oct 15, 2020	CareDx to Report Third Quarter 2020 Financial Results SOUTH SAN FRANCISCO, Calif. , Oct. 15, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML